文献速递慢性肾脏病

非氧化PTH与总PTH评估CKD骨转换无优劣差异

Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease.
PubMed 文献 · Kidney Int · 2021-01-08

该研究在31例肾衰竭患者中比较非氧化PTH与总PTH评估骨转换的能力,患者选自正在进行的骨活检前瞻性观察研究并覆盖骨转换全谱。结果显示两者与骨转换指标相关性相似,鉴别低/非低及高/非高骨转换的AUROC相当,非氧化PTH无额外价值。

要点

  • 非氧化PTH与总PTH评估骨转换能力相当。
  • 当前方法测非氧化PTH不优于总PTH。
  • 肾衰竭患者骨转换标志物相关性相似。

核心结论

  • 当前方法测定的非氧化PTH在评估肾衰竭患者骨转换方面较总PTH无额外价值。

研究设计与样本

  • 来自正在进行的骨活检前瞻性观察研究,纳入31例肾衰竭患者并覆盖骨转换全谱。

主要发现

  • 非氧化PTH与总PTH血清水平呈强且显著相关。
  • 骨组织形态计量学参数及循环骨转换标志物与两种PTH的相关系数相似。
  • 鉴别低/非低骨转换的AUROC:非氧化PTH 0.82,总PTH 0.79,均显著且相当。
  • 鉴别高/非高骨转换的AUROC:非氧化PTH 0.76,总PTH 0.80,均显著且量级相同。

临床怎么用

  • 临床评估肾衰竭患者骨转换时,当前方法测非氧化PTH不优于总PTH。

局限性

  • 样本量仅31例肾衰竭患者,结果需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Parathyroid hormone (PTH) is a key regulator of bone turnover but can be oxidized in vivo, which impairs biological activity. Variable PTH oxidation may account for the rather poor correlation of PTH with indices of bone turnover in chronic kidney disease. Here, we tested whether non-oxidized PTH is superior to total PTH as a marker of bone turnover in 31 patients with kidney failure included from an ongoing prospective observational bone biopsy study and selected to cover the whole spectrum of bone turnover. Receiver Operating Characteristic (ROC) curves, Spearman correlation and regression analysis of non-oxidized PTH, total PTH and bone turnover markers (bone-specific alkaline phosphatase, procollagen N-terminal pro-peptide and tartrate-resistant acid phosphatase 5b) were used to assess the capability of non-oxidized PTH vs. total PTH to discriminate low from non-low and high from non-high bone turnover, as assessed quantitatively by bone histomorphometry. Serum levels of non-oxidized PTH and total PTH were strongly and significantly correlated. Histomorphometric parameters of bone turnover and the circulating bone turnover markers showed similar correlation coefficients with non-oxidized PTH and total PTH. The area under the ROC (AUROC) values for discriminating between low/non-low turnover for non-oxidized PTH and total PTH were significant and comparable (0.82 and 0.79, respectively). For high/non-high turnover the AUROCs were also significant and of the same magnitude (0.76 and 0.80, respectively). Thus, measuring non-oxidized PTH using the currently available method provides no added value compared to total PTH as an indicator of bone turnover in patients with kidney failure.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Ursem SR, Heijboer AC, D'Haese PC, et al. Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease. Kidney Int. 2021. PMID: 33422551. doi:10.1016/j.kint.2020.12.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。